Artificial sweeteners can alter gut signaling and appetite regulation, and some people report increased cravings or mild digestive upset
Effect of semaglutide on the pharmacokinetics of metformin, warfarin, atorvastatin and digoxin in healthy subjects
Troubleshooting common problems is another important section
Study Design and Treatment Two open-label, one-sequence, crossover clinical pharmacology studies investigated the effect of once-weekly subcutaneous semaglutide 1.0 mg steady state on the pharmacokinetics of metformin, warfarin, atorvastatin and digoxin, and the pharmacodynamics of warfarin (NCT02022254, NCT02243098)
J., Kraakman, M
The risk of NAION is very rare compared to the massive reduction in cardiovascular events and overall mortality seen in GLP-1 trials